Expert in AI and biology Amelie Schreiber discusses the AI revolution in drug design and protein engineering. Topics include using AI for protein network engineering, predicting protein structures with AlphaFold, and the implications for human health and biological research. Explore how AI is transforming biology and medicine, the challenges of utilizing new research tools, and the risks and benefits of AI advancements in the field.

Amelie Schreiber, a computational biochemist and AI researcher, discusses groundbreaking advancements in AI's role in biology. She dives into tools like AlphaFold3 and ESM3, which are transforming protein engineering and drug discovery. The conversation explores the challenges of making these innovations accessible and touches on the importance of recent Nobel Prize awards recognizing AI’s impact. Schreiber also shares insights on efficient protein design, enzyme dynamics, and how AI is reshaping molecular research.